
Synovics Pharmaceuticals, Inc.
Share · US87163M1018 (OTC)
No Price
Closing Price OTC 30.10.2025:
0,0001 USD
30.10.2025 20:00
Current Prices from Synovics Pharmaceuticals, Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
SYVC
|
USD
|
30.10.2025 20:00
|
0,0001 USD
| 0,00 USD |
Company Profile for Synovics Pharmaceuticals, Inc. Share
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
Company Data
Name Synovics Pharmaceuticals, Inc.
Company Synovics Pharmaceuticals, Inc.
Primary Exchange
UTC
ISIN US87163M1018
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO John R. Palmer
Country United States of America
Currency USD
Employees 0,2 T
Address 5360 Northwest 35th Avenue, Fort Lauderdale
IPO Date 2023-06-26
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | SYVC |
More Shares
Investors who hold Synovics Pharmaceuticals, Inc. also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.


